Biotech startup DROPLET GENOMICS raises €1 million from PRACTICA CAPITAL to commercialize droplet microfluidics technology

Vilnius, Lithuania, January 27, 2021 – Droplet Genomics, a Lithuanian biotech startup, has today announced that it has raised a total of €1M in a Seed funding round led by Practica Capital, with contribution from Angel investors. Droplet Genomics is a Lithuanian biotech startup that aims to commercialize droplet microfluidics technology. Owing to its unparalleled…

Science and business professionals presented the development of bioeconomy and life sciences in Lithuanian regions

On 15 October, the Lithuanian Biotechnology Association started an event tour of Lithuanian regions “Bioeconomy and Life Sciences Development Opportunities in Lithuanian Regions”. Researchers and biotechnology industry representatives invited regional municipalities and local businesses to discuss regional involvement in the development of innovative technologies. The bioeconomy and life sciences play an important role in Lithuania’s…

“Bioeconomy and Life Sciences Development Opportunities in Lithuanian Regions” event tour has successfully reached its end

The event tour of Lithuanian regions “Bioeconomy and Life Sciences Development Opportunities in Lithuanian Regions”, organised by the Lithuanian Biotechnology Association, reached the finnish on the 13th of November. After the first visit to Telsiai, due to the spread the COVID-19 infection, it was decided to transfer the tour events to the remote format, thus…

Northway Biotech opens new biopharmaceutical manufacturing facility in Greater Boston Area

Waltham, MA, US – January 20, 2021 – Northway Biotech, a biopharmaceutical contract development and manufacturing organization (CDMO), established in 2004, with an EMA and FDA-compliant, state-of-the-art, cGMP manufacturing site in Europe, announced at the virtual grand opening ceremony today, the opening of its new 30,000 square-foot process development and cGMP manufacturing site in Waltham,…

Northway Biotechpharma announces company name change to Northway Biotech

Vilnius, Lithuania, and Waltham, MA, US – December 9, 2020 – Northway Biotechpharma, providing end-to-end contract drug development and manufacturing (CDMO) services, announces brand name change to Northway Biotech. Along with the tradename change, Dr. Vladas Algirdas Bumelis also returns to the helm as Chief Executive Officer at the company he founded. “We are expanding…

Biomatter Designs raises €500k to develop AI for Generative Protein Design

Computationally engineered enzyme (gray) for enhanced stability, bound to DNA (red). Biomatter Designs raises €500k to develop AI for Generative Protein Design Vilnius-born startup Biomatter Designs that pioneers the technologies for generative protein design, has raised €500,000 in seed funding led by Practica Capital, accompanied by 70V and angel investors. The raised capital will be…

Welcome to our newest members – UAB Bioversija

At the end of this year, company UAB Bioversija joined the Lithuanian Biotechnology Association. UAB Bioversija develops efficient and environmentally sustainable biological products for the agriculture. The aim of the company is searching effective biological alternatives for the chemical products used in agriculture. The products developed by the company’s professionals are based on unique microorganisms…